Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome


Por: Boissier, F, Katsahian, S, Razazi, K, Thille, AW, Roche-Campo, F, Leon, R, Vivier, E, Brochard, L, Vieillard-Baron, A, Brun-Buisson, C, Dessap, AM

Publicada: 1 oct 2013
Resumen:
Pulmonary vascular dysfunction is common during acute respiratory distress syndrome (ARDS), but there is controversy concerning prevalence and prognosis of cor pulmonale during protective ventilation for ARDS. This was a prospective observational study in an academic medical intensive care unit in France. Two hundred and twenty-six consecutive patients with moderate to severe ARDS (Berlin definition) ventilated with plateau pressure limited at 30 cmH(2)O (mean PEEP of 8.8 +/- A 3.6 cmH(2)O) underwent transesophageal echocardiography (TEE) within the first 3 days after the diagnosis of ARDS. Cor pulmonale was defined as a dilated right ventricle associated with septal dyskinesia. Cor pulmonale was detected in 49 patients (prevalence of 22 %; 95 % confidence interval, 16-27 %). Multivariate logistic regression identified infectious causes of lung injury and higher driving pressures as independent factors associated with cor pulmonale. Patients with cor pulmonale exhibited a higher incidence of shock (need for vasoactive drug) at the time of TEE and were more often managed with prone positioning and/or nitric oxide as adjunctive therapy for severe hypoxemia during ARDS course. The 28-day mortality rate was significantly higher in the group with cor pulmonale (60 vs. 36 %, p < 0.01). Multivariate logistic regression identified McCabe and Jackson class, lung injury not related to pneumonia, aspiration, or sepsis, lactic acidosis, driving pressure, and cor pulmonale as independent risk factors for 28-day mortality. Cor pulmonale occurrence is not negligible in ARDS patients ventilated with airway pressure limitation. Cor pulmonale was associated with sepsis and higher values of driving pressure and was an independent risk factor for 28-day mortality in our series.

Filiaciones:
Boissier, F:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

 Hop Henri Mondor, INSERM, Unite IMRB U955, F-94010 Creteil, France

 Univ Paris Est Creteil Val de Marne, Fac Med, F-94010 Creteil, France

Katsahian, S:
 Grp Henri Mondor Albert Chenevier, AP HP, Clin Res Unit, F-94010 Creteil, France

Razazi, K:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

Thille, AW:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

Roche-Campo, F:
 Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain

Leon, R:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

Vivier, E:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

Brochard, L:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

Vieillard-Baron, A:
 Hop Ambroise Pare, AP HP, Serv Reanimat, F-92100 Boulogne, France

Brun-Buisson, C:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

 Hop Henri Mondor, INSERM, Unite IMRB U955, F-94010 Creteil, France

 Univ Paris Est Creteil Val de Marne, Fac Med, F-94010 Creteil, France

Dessap, AM:
 Grp Henri Mondor Albert Chenevier, AP HP, Serv Reanimat Med, F-94010 Creteil, France

 Hop Henri Mondor, INSERM, Unite IMRB U955, F-94010 Creteil, France

 Univ Paris Est Creteil Val de Marne, Fac Med, F-94010 Creteil, France
ISSN: 03424642





INTENSIVE CARE MEDICINE
Editorial
SPRINGER, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Estados Unidos America
Tipo de documento: Article
Volumen: 39 Número: 10
Páginas: 1725-1733
WOS Id: 000324233200006
ID de PubMed: 23673401

MÉTRICAS